In this issue of the Journal, an expert panel offers 7 recommendations on how population studies supported by National Heart, Lung, and Blood Institute contracts might be strategically transformed (Am J Epidemiol. 2015;181(6):363-368). The Institute and its external advisors seemingly established this panel of epidemiologists and nonepidemiologists primarily to find ways to save research costs. Although the working group's recommendations offer reasonable approaches, we believe that, even in tough fiscal times, the main drivers of cardiovascular epidemiologic research must remain 1) scientific questions that are important and 2) study designs to match these. Although cardiovascular epidemiology admittedly is often redundant and needs to be more efficient, undue focus on administrative efficiency and cost savings will not necessarily guarantee cutting-edge population research.
Bibliographical notePublisher Copyright:
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
- cardiovascular disease
- cohort studies
- epidemiologic methods
- prospective studies